Dr. Anthony Fauci, chief medical advisor to the President, and top officials at the National Institute of Allergy and Infectious Diseases (NIAID) changed the endpoint for remdesivir during the middle of its clinical trial to make the drug look effective, internal emails show. Just hours after Fauci announced the results of the remdesivir trial, internal emails […]